Cbz-n-amido-peg2-acid

Catalog No.: 
ACLFSX429
CAS No.: 
1347750-76-8
Molecular Formula: 
C15H21NO6
Molecular Weight: 
311.33
Cbz-n-amido-peg2-acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$95.00In stockIn stock
5g95%$419.00In stockIn stock
25g95%$1927.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameCbz-n-amido-peg2-acid
IUPAC Name3-oxo-1-phenyl-2,7,10-trioxa-4-azatridecan-13-oic acid
MDL No.MFCD28142483
Molecular FormulaC15H21NO6
Molecular Weight311.33
SMILESOC(CCOCCOCCNC(OCC1=CC=CC=C1)=O)=O
InChI KeyXOMNIRHPTPYIMF-UHFFFAOYSA-N
Synonym3-Oxo-1-phenyl-2,7,10-trioxa-4-azatridecan-13-oic acid | HY-140487 | SCHEMBL18886422 | CBZ-NH-PEG2-acid | BP-22313 | AKOS027320767 | Cbz-NH-PEG2-C2-acid | XDC75076 | J-006602 | SY273101 | WS-03065 | 3-[2-(2-Benzyloxycarbonylamino-ethoxy)-ethoxy]-propionic
CAS No.1347750-76-8
PubChem CID86276404

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACLFSX429 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLTJQ536 route compound structure diagram
    ACLTJQ536791028-27-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLFSX429 route product structure diagram
    ACLFSX4291347750-76-8In Stock
Inquiry

2. ACLFSX429 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLFSX429 route product structure diagram
    ACLFSX4291347750-76-8In Stock
Inquiry

3. ACLFSX429 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLFSX429 route product structure diagram
    ACLFSX4291347750-76-8In Stock
Inquiry

Comments (0)